Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Chida

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Nephron|January 1, 1992
Effect of thrombocytopenia on the onset of immune complex glomerulonephritisT Ideura, M Ogasawara, S Tomura, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysisT Akiba, K Tachibana, K Ozawa, et al.
Thrombosis Research|May 15, 1990
Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapyS Tomura, Y Nakamura, F Deguchi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 1998
Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidismT Akiba, F Marumo, A Owada, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1996
Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patientsS Tomura, Y Nakamura, M Doi, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Nephron|January 1, 1992
Effect of thrombocytopenia on the onset of immune complex glomerulonephritisT Ideura, M Ogasawara, S Tomura, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysisT Akiba, K Tachibana, K Ozawa, et al.
Thrombosis Research|May 15, 1990
Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapyS Tomura, Y Nakamura, F Deguchi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 1998
Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidismT Akiba, F Marumo, A Owada, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1996
Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patientsS Tomura, Y Nakamura, M Doi, et al.
Pageof 5